Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for LENZ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 220.00M
March 31, 2026 258.38M
December 31, 2025 292.35M
September 30, 2025 202.17M
June 30, 2025 209.63M
March 31, 2025 194.09M
December 31, 2024 209.14M
September 30, 2024 217.22M
June 30, 2024 196.23M
March 31, 2024 213.39M
December 31, 2023 65.79M
September 30, 2023 233.99M
Date Value
June 30, 2023 246.66M
March 31, 2023 264.10M
December 31, 2022 268.23M
September 30, 2022 291.68M
June 30, 2022 322.29M
March 31, 2022 339.18M
December 31, 2021 376.98M
September 30, 2021 394.95M
June 30, 2021 382.11M
March 31, 2021 177.16M
December 31, 2020 19.82M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Ocular Therapeutix, Inc. 598.64M
Enveric Biosciences, Inc. 8.296M
Liquidia Corp. 284.18M
Aquestive Therapeutics, Inc. 98.49M
Impact BioMedical, Inc. 0.01M